Insurance Coverage · Last verified: April 24, 2026
By The RX Index Editorial Team · CVS Caremark 2026 formulary documents reviewed · Foundayo FDA label and savings card terms verified · LillyDirect, Ro, and Sesame Care pricing confirmed
Does CVS Caremark Cover Foundayo?
(April 2026 Verified Answer)
Probably not — on the standard formularies we checked.
Foundayo (orforglipron) got FDA approval on April 1, 2026. We did not find Foundayo or orforglipron in CVS Caremark's January 2026 Standard Control with Advanced Control Specialty Formulary (SCF/ACSF) or in the April 2026 public Standard Control Plan PDF. CVS Caremark's Performance Drug List states that new-to-market products are not added to the formulary immediately.
But your actual coverage depends on your specific plan. Some employer-customized plans may have added Foundayo or set up an exception process. Verify your own plan first — it takes under 5 minutes using the script below.
$25/mo
With qualifying commercial coverage + Foundayo Savings Card
$149/mo
Self-pay starting dose (0.8 mg) — LillyDirect, Ro, Sesame Care
What we actually verified (April 24, 2026)
- CVS Caremark January 2026 SCF/ACSF Performance Drug List and April 2026 public Standard Control Plan PDF — Foundayo/orforglipron not found in either
- Foundayo FDA approval (April 1, 2026) and Foundayo Savings Card terms on foundayo.lilly.com
- LillyDirect, Ro, and Sesame Care pricing pages as of the verification date
- CMS Medicare GLP-1 Bridge launch details (July 1 – December 31, 2027)
- CVS Caremark's prior authorization and formulary exception processes
We did not access any private CVS Caremark member account. No public page can tell you what your specific plan covers — only Caremark.com or your plan's member line can do that.
Your CVS Caremark result → what it means → what to do next
Whatever you see when you check your plan maps to one of these six outcomes. Each has a different next step.
| Your Caremark.com result | What it usually means | Fastest next step |
|---|---|---|
| Foundayo covered, no PA | Your plan added it (rare right now) | Get the Foundayo Savings Card, fill it |
| Foundayo covered, PA required | Coverage is possible; paperwork decides | Submit ePA with full documentation |
| Foundayo non-formulary | Exception may work, not guaranteed | Request formulary exception criteria |
| Foundayo excluded / not covered | Benefit design blocks it; PA won't fix this | Ask HR first, then self-pay path |
| Drug not found | Too new, not loaded yet, or wrong search | Call Caremark; search 'orforglipron' too |
| Medicare Part D | Separate rules via CMS Medicare GLP-1 Bridge | See Medicare section below |
Does CVS Caremark cover Foundayo in April 2026?
As of April 2026, Foundayo and orforglipron were not found in the CVS Caremark documents we checked. Foundayo received FDA approval on April 1, 2026. CVS Caremark's Performance Drug List states that new-to-market products are not added immediately and must be evaluated by the P&T Committee.
Here's the part most coverage guides skip: CVS Caremark isn't one formulary — it's a family of template formularies plus thousands of customized employer plans. So when someone asks "does CVS Caremark cover Foundayo," the honest answer is: we can look at the template, but we can't see your plan.
1. Foundayo/orforglipron was not found in the January 2026 CVS Caremark SCF/ACSF Performance Drug List or the April 2026 public Standard Control Plan PDF. That's the factual audit result — it doesn't prove every plan excludes Foundayo, but it's the starting point.
2. CVS Caremark's Performance Drug List explicitly states that new-to-market products are not added to the formulary immediately. Each new product is evaluated for clinical appropriateness and cost-effectiveness before being reviewed by the P&T Committee.
3. Per PSG Consulting's January 2026 analysis, CVS Caremark made no GLP-1 coverage changes effective January 1, 2026. Wegovy remains preferred. Zepbound remains excluded on the main standard formularies.
Why might CVS Caremark prefer Wegovy over Foundayo?
In May 2025, CVS Caremark announced a preferred partnership with Novo Nordisk placing Wegovy (semaglutide) on its largest commercial template formularies as the preferred GLP-1 for weight loss. The preferred slot is taken — and it's taken by Novo Nordisk, not Lilly.
| Date | What happened |
|---|---|
| May 2025 | Novo Nordisk and CVS Caremark announce Wegovy preferred GLP-1 on CVS Caremark's largest commercial template formularies at a lower net price than Zepbound |
| July 1, 2025 | Change takes effect. Zepbound becomes excluded on Standard Control, Advanced Control, and Value formularies (~25–30 million covered individuals per CNN September 2025) |
| September 2025 | Class-action lawsuit Larkin v. Caremark RX (S.D.N.Y.) filed challenging the Zepbound exclusion |
| January 1, 2026 | Per PSG Consulting formulary analysis, no GLP-1 changes effective. Wegovy preferred, Zepbound excluded on main standard formularies |
| April 1, 2026 | Foundayo gets FDA approval. Not on CVS Caremark standard formularies we checked. CVS Caremark has made no public announcement about Foundayo coverage as of verification date |
The honest editorial read
CVS Caremark's recent track record on Lilly weight-loss medications doesn't favor fast Foundayo coverage. The PBM just made Wegovy its preferred brand. It would be strategically inconsistent to then prefer another Lilly GLP-1 that competes directly with the product they just negotiated to prefer. What would change this? A meaningful Foundayo list-price cut from Lilly, a second FDA indication (T2D), or a decision that Foundayo's oral convenience justifies non-preferred coverage. None confirmed today.
How to check your own CVS Caremark Foundayo coverage in under 5 minutes
Step 1: Log in to Caremark.com
- Go to Caremark.com or open the CVS Caremark mobile app
- Sign in and click Check Drug Cost & Coverage
- Search Foundayo
- If nothing comes up, search orforglipron (the generic name)
- Select the dose if prompted
- Screenshot the result — it's the single most useful piece of paperwork for any phone call or appeal that follows
Step 2: Call CVS Caremark if the result is unclear
Call the number on the back of your CVS Caremark member ID card. Use this exact script:
"Hi, I need to verify coverage for a prescription medication on my plan. Can you please tell me:
- Is Foundayo — generic name orforglipron, manufacturer Eli Lilly — on my plan's formulary as of today?
- If it's on the formulary, what tier is it and what would my copay or coinsurance be at the 0.8mg starting dose for a 30-day supply?
- Is prior authorization required? If yes, what are the clinical criteria?
- Is step therapy required — meaning do I need to try Wegovy or another GLP-1 first?
- If Foundayo is excluded, is it non-formulary with an exception process available, or is it a plan exclusion that can't be approved through PA?
- Can you note this conversation in my file with today's date and give me a reference number?"
The distinction in question 5 is the one that changes everything. Write down their answer word for word.
Step 3: If your plan is through an employer, also call HR
Your employer decides benefit design. CVS Caremark just administers what your employer bought. Ask HR or your benefits administrator:
"Does our prescription plan include coverage for FDA-approved weight-management medications, specifically GLP-1 drugs? If not, is that exclusion in the CVS Caremark template we use, or did we add it as a plan-specific exclusion?"
If your employer excluded weight-loss medications, no amount of prior authorization paperwork will fix it. Ask the exclusion question first — it saves weeks of wasted appeals.
Rather skip the hold music?
Ro's free GLP-1 Insurance Coverage Checker
Ro says its team contacts your insurance company by phone to complete a personalized GLP-1 coverage report — including whether prior authorization is required and your estimated copay. If your plan covers Foundayo with PA required, Ro's insurance concierge submits the prior authorization paperwork as part of its weight-loss program. Ro carries Foundayo at Lilly's published self-pay pricing if insurance doesn't come through, so you have a fallback either way.
Check your Foundayo coverage on Ro (free) →Affiliate link — we may earn a commission at no cost to you.
What does my CVS Caremark Foundayo result actually mean?
A CVS Caremark coverage result isn't binary. There are six common outcomes, and each needs a different response. Confusing a non-formulary result with a plan exclusion wastes weeks on an appeal that can't succeed.
Outcome 1: Covered, no prior authorization
What it means: Your plan currently covers Foundayo without gatekeeping. Rare as of April 2026 — Foundayo is too new for most plans — but a small number of employer plans may have fast-tracked it.
What to do: Get your prescription sent to your preferred pharmacy, apply for the Foundayo Savings Card at foundayo.lilly.com if you have commercial insurance, and fill it.
Outcome 2: Covered, prior authorization required
What it means: Coverage is possible, but CVS Caremark wants documentation before they'll pay. This is the most common path when a GLP-1 weight-loss drug is covered.
What to do: Your prescriber submits an electronic prior authorization (ePA) through their EHR via Surescripts or CoverMyMeds. Full PA checklist in the next section.
Outcome 3: Non-formulary
What it means: Foundayo isn't on your plan's formulary, but CVS Caremark may allow a formulary exception request if your prescriber can document medical necessity. Non-formulary is NOT the same as plan-excluded.
What to do: Ask for the exception criteria, then your prescriber submits a formulary exception request. Documentation requirements are higher than for standard PA — you'll need to show why Foundayo is medically necessary over the preferred alternative (typically Wegovy).
Outcome 4: Drug not covered / plan exclusion
What it means: Your employer's benefit design excludes Foundayo — often as part of a broader weight-loss medication exclusion. Prior authorization typically cannot overturn a plan exclusion, because it's not a clinical decision, it's a benefit design decision.
What to do: Confirm with HR whether the exclusion is plan-level or CVS Caremark template-level. If it's your employer's choice: (1) HR advocacy at open enrollment, (2) self-pay, or (3) ERISA benefits counsel if the denial conflicts with plan language.
Outcome 5: Drug not found
What it means: Either the drug hasn't been loaded into your plan's system yet (common for drugs approved less than 90 days ago), the Caremark search didn't recognize the name, or there's a coding issue. Very common for Foundayo right now.
What to do: Search 'orforglipron' (the generic name) if you searched 'Foundayo' first. Call Caremark and explicitly ask whether any Foundayo NDCs are in their system for your plan.
Outcome 6: Medicare Part D plan
What it means: You're on Medicare, which currently does not cover weight-loss medications through Part D. The CMS Medicare GLP-1 Bridge launches July 1, 2026 — that's a separate pathway outside normal Part D coverage.
What to do: See the Medicare section below for Bridge eligibility criteria and immediate self-pay options.
What if CVS Caremark covers Foundayo but requires prior authorization?
If your CVS Caremark plan covers Foundayo with prior authorization required, your prescriber needs to submit clinical documentation meeting the standard GLP-1 weight-management criteria.
The standard CVS Caremark GLP-1 PA criteria
| PA requirement | What your prescriber documents |
|---|---|
| BMI threshold | Current BMI ≥30, OR BMI ≥27 with comorbidity |
| Comorbidity (if BMI 27–29.9) | Hypertension, T2D, dyslipidemia, CV disease, OSA, or other weight-related condition with ICD-10 code |
| Clinical justification | Medical necessity statement for Foundayo specifically |
| Lifestyle attempts | Documentation of reduced-calorie diet, increased physical activity, or lifestyle modification efforts |
| Safety review | No personal or family history of MTC or MEN2 (contraindicated); no serious hypersensitivity to orforglipron (contraindicated); review of pancreatitis history, gallbladder disease, kidney/GI issues, hypoglycemia risk, oral contraceptive interactions |
| Chart notes | Full visit notes supporting the diagnosis and prescription, not just the prescription itself |
Why documentation quality matters more than you'd think
PA denials that end up in appeals are overwhelmingly denials where the documentation was weak. Common weak spots:
- "Patient wants weight loss" instead of a specific medical necessity statement
- BMI noted in chart from 2 years ago — plans want recent documentation
- Comorbidity mentioned but no ICD-10 code
- No response-to-alternative history — if your prescriber wrote "patient requested Foundayo" without noting why Wegovy isn't appropriate, expect extra back-and-forth
Don't want to chase your prescriber on paperwork?
Ro's insurance concierge handles the prior authorization paperwork for patients in its weight-loss program. If PA is required, Ro's team submits the documentation and follows up with the insurer. You get status updates instead of phone tag.
Ro Body membership: $39 for the first month, then as low as $74/month with annual plan paid upfront (or $149/month standard). Membership and medication billed separately.
See Ro Foundayo pricing and start a free coverage check →What if CVS Caremark excludes Foundayo?
Your next step depends on which type of denial you received. Non-formulary denials can sometimes be overturned through a formulary exception request. True plan exclusions — where your employer designed the benefit to not cover weight-loss medications — generally cannot be reversed through prior authorization.
Filing a formulary exception: the step-by-step
Step 1: Request the specific exception criteria in writing
When you call, ask: "What documentation do you need for a formulary exception for Foundayo?" Get it emailed to you if possible.
Step 2: Identify your medical necessity case
Exception requests succeed when they answer: why is Foundayo medically necessary for this patient specifically, when the preferred alternative exists? Strong cases include: you tried Wegovy and had intolerable side effects; you tried Wegovy and didn't achieve sufficient weight loss (<5% body weight after 12+ weeks at a therapeutic dose); or a prescriber-documented reason the preferred alternative isn't clinically appropriate.
Step 3: Submit through the right channel
Via ePA through your prescriber's EHR (Surescripts or CoverMyMeds — fastest), or by fax (verify the correct number for your specific form and plan).
Step 4: If denied, understand your appeal options
You typically have internal appeal rights after an initial denial. If the internal appeal is denied, external review may be available depending on plan type and denial reason.
When it's a plan exclusion, not a non-formulary decision
If HR confirms your employer excluded weight-loss medications, prior authorization usually cannot overturn a benefit exclusion. The drug isn't being denied for clinical reasons; the benefit you bought doesn't include it. Your realistic paths:
- Open enrollment advocacy — work with HR to add GLP-1 weight-loss coverage at the next plan year
- ERISA benefits appeal — for employer plans, if the denial conflicts with plan language or documented medical conditions, benefits counsel may be worth considering
- Self-pay in the meantime — self-pay starts at $149/month. You're not stuck waiting
How much does Foundayo cost with and without CVS Caremark coverage?
With coverage + Foundayo Savings Card: as low as $25/month
Foundayo Savings Card terms (verified April 24, 2026)
- Eligible patients: commercially insured, with a plan that covers Foundayo
- Your copay: as low as $25 for a 1-month, 2-month, or 3-month fill
- Maximum savings: $100 off a 1-month fill; $200 off 2-month; $300 off 3-month
- Annual cap: $1,000 per calendar year; up to 10 fills
- Card expires: December 31, 2026 (Lilly can modify at its discretion)
- Not eligible: Medicare, Medicare Part D, Medicare Advantage, Medicaid, TRICARE, VA, DoD, or any government healthcare program
Important: the savings card only brings you to $25/month if your plan already covers Foundayo. It does NOT override a plan exclusion.
Without coverage: verified self-pay pricing by dose
| Foundayo dose | LillyDirect | Ro | Sesame Care |
|---|---|---|---|
| 0.8 mg (starter) | $149/mo | $149/mo | $149/mo |
| 2.5 mg | $199/mo | $199/mo | $199/mo |
| 5.5 mg | $299/mo | $299/mo | $299/mo |
| 9 mg | $299/mo | $299/mo | $299/mo |
| 14.5 mg | $349/mo regular* | $349/mo regular* | $349/mo regular* |
| 17.2 mg | $349/mo regular* | $349/mo regular* | $349/mo regular* |
*For 14.5mg and 17.2mg doses, $299/month is only available through the Foundayo Self-Pay Journey Program if you refill within 45 days of your previous fill. Miss the 45-day window and the price is $349/month.
12-month self-pay cost estimate
Assuming standard titration (0.8mg → 2.5mg → 5.5mg → 9mg, reaching maintenance by month 4) and staying enrolled in the refill program:
- Months 1–3 (titration): $149 + $199 + $299 = $647
- Months 4–12 (maintenance at 9mg): 9 × $299 = $2,691
- 12-month total: roughly $3,338
If your CVS Caremark plan covers Foundayo and you use the savings card for 10 fills: roughly $350–$550 for the year. The difference between covered and self-pay is roughly $2,800–$3,800/year. That's the math behind why verifying your coverage is worth 10 minutes.
Ro vs LillyDirect vs Sesame Care — who's the right pick?
| Channel | Medication cost | What's included | Best fit for |
|---|---|---|---|
| LillyDirect | Lilly's published self-pay price | Manufacturer-direct pharmacy; shipping | You have your own prescriber and want manufacturer-direct |
| Ro | Same Lilly-matched pricing (medication billed separately from membership). Membership: $39 first month, then $149/mo or $74/mo with annual prepay | Clinical visits, coaching, insurance concierge, free GLP-1 Insurance Coverage Checker | You want clinical care included and help with insurance |
| Sesame Care | Same Lilly-matched pricing; Sesame also says insurance accepted for weight-loss medications. Subscription: $59/mo annual or $99/mo monthly | Provider-choice marketplace | You want to pick your specific clinician |
Our editorial pick for most CVS Caremark members
Ro. Reasoning: your main friction isn't finding a clinician — it's navigating the insurance question. Ro is the only option that checks coverage for you, handles PA paperwork if covered, and falls back to self-pay at Lilly's prices if not. Where Ro isn't the right fit: if you already have an established prescriber you trust, or if you specifically want to pick your clinician, Sesame Care or LillyDirect is a cleaner path.
Does Medicare with CVS Caremark cover Foundayo?
Medicare Part D does not currently cover Foundayo for weight loss. Under the Medicare Modernization Act of 2003, Medicare Part D is prohibited from covering medications used for weight loss. Starting July 1, 2026, the CMS Medicare GLP-1 Bridge creates a separate access pathway for eligible Medicare beneficiaries.
CMS Medicare GLP-1 Bridge key facts
- Timeline: July 1, 2026 through December 31, 2027
- Structure: operates outside normal Part D coverage and payment flow
- Central processor: a single central processor handles Bridge prescriptions — not individual Part D plans
- Plan opt-in: Part D sponsors do not have to opt in for eligible beneficiaries to access Bridge drugs
- Covered drugs: include FDA-approved weight-management GLP-1s, Foundayo among them
Medicare GLP-1 Bridge eligibility criteria (per CMS)
Criteria require ongoing lifestyle modification plus age 18+ and one of the following:
- BMI ≥35 at GLP-1 initiation
- BMI ≥30 with heart failure with preserved ejection fraction (HFpEF), uncontrolled hypertension, or CKD stage 3a or above
- BMI ≥27 with prediabetes, previous myocardial infarction, previous stroke, or symptomatic peripheral artery disease
These are tighter than commercial PA criteria. Your prescriber submits the Bridge PA to the central processor, not to your Part D plan.
Important: Foundayo Savings Card cannot be used by Medicare beneficiaries
Lilly explicitly excludes Medicare, Medicaid, TRICARE, VA, DoD, and all government beneficiaries from the $25/month commercial savings card. If you're on Medicare right now and want Foundayo before July 1, 2026: LillyDirect self-pay at $149/month for the starter dose is the cleanest immediate option.
A few important Foundayo medical notes before anyone prescribes it
A fast medical orientation. Talk to a licensed prescriber about your specific situation.
FDA Boxed Warning — Thyroid C-Cell Tumor Risk
Observed in animal studies. Foundayo is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC), patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN2), and patients with a history of serious hypersensitivity to orforglipron.
FDA-approved use
Foundayo is approved for adults with obesity (BMI ≥30) OR adults with overweight (BMI ≥27) with at least one weight-related condition (hypertension, T2D, dyslipidemia, obstructive sleep apnea, or cardiovascular disease), used together with a reduced-calorie diet and increased physical activity.
Key warnings and precautions
- Acute pancreatitis, severe gastrointestinal reactions, acute kidney injury from dehydration
- Hypoglycemia — higher risk with insulin or sulfonylureas
- Serious hypersensitivity reactions; diabetic retinopathy complications (T2D patients); acute gallbladder disease
- Pulmonary aspiration during general anesthesia and deep sedation
- Do not combine with other GLP-1 receptor agonists
- Oral birth control note: your provider may recommend another type of birth control for 30 days after starting Foundayo and 30 days after each dose increase
Common side effects
Nausea, constipation, diarrhea, vomiting, indigestion, abdominal pain, headache, swollen belly, fatigue, belching, heartburn, gas, hair loss. Always review the full prescribing information with your clinician.
How we verified this page
Sources we checked
- CVS Caremark January 2026 SCF/ACSF Performance Drug List and April 2026 public Standard Control Plan PDF
- CVS Caremark's Check Drug Cost & Coverage member tool, prior authorization pages, and formulary exception process documentation
- CVS Caremark's May 2025 Wegovy preferred-partnership announcement with Novo Nordisk
- FDA approval announcement for Foundayo (April 1, 2026) and the DailyMed label
- Eli Lilly's Foundayo product pages and the full Foundayo Savings Card / Self-Pay Journey Program terms
- LillyDirect, Ro, and Sesame Care pricing pages (verified April 24, 2026)
- CMS Medicare GLP-1 Bridge announcements and criteria
- PSG Consulting's January 2026 analysis of CVS Caremark 2026 formulary changes
- CNN, NPR, Becker's Hospital Review, and BioPharma Dive reporting on CVS Caremark's GLP-1 coverage decisions
- Public docket information for Larkin v. Caremark RX (S.D.N.Y., filed September 2025)
What we explicitly did not do
- We did not access any individual CVS Caremark member account
- We did not audit every CVS Caremark template formulary or employer-customized plan
- We did not use compounded GLP-1 products as a comparison to Foundayo
We verify this page monthly on the 1st of each month, or within 48 hours of any material change (formulary announcement, pricing change, lawsuit update, Medicare GLP-1 Bridge launch details). The "Last verified" date reflects the most recent verification.
Frequently asked questions about CVS Caremark and Foundayo
Does CVS Caremark cover Foundayo?
Maybe — it depends on your specific plan. In the CVS Caremark 2026 SCF/ACSF Performance Drug List and April 2026 public Standard Control Plan PDF we checked, Foundayo and orforglipron were not found. Employer-customized plans may differ. Check Caremark.com to verify your specific plan.
Is Foundayo on the CVS Caremark Standard Control Formulary?
In the January 2026 SCF/ACSF Performance Drug List and the April 2026 Standard Control Plan PDF we checked, Foundayo and orforglipron were not found. Wegovy was listed as the preferred GLP-1 for weight loss; Zepbound forms were listed as non-formulary.
Does CVS Caremark cover orforglipron?
Orforglipron is the generic name for Foundayo. Same answer — search both names on Caremark.com because search tools sometimes index differently.
Does Foundayo require prior authorization on CVS Caremark?
If your CVS Caremark plan covers Foundayo, prior authorization is very likely. Standard criteria include BMI ≥30 (or BMI ≥27 with a weight-related condition), documentation of lifestyle modification efforts, and confirmation of no contraindications (MTC, MEN2, or serious hypersensitivity to orforglipron).
What if CVS Caremark denies my Foundayo prior authorization?
First, get the specific denial reason in writing. If it's a medical-necessity denial, your prescriber can file an appeal with additional documentation. If it's a non-formulary denial, you can request a formulary exception. If it's a plan exclusion, PA generally cannot overturn it — your paths are HR advocacy, benefits counsel (for ERISA-governed employer plans where the denial conflicts with plan language), or self-pay.
Can I appeal a CVS Caremark denial for Foundayo?
Yes. After an initial denial, you typically have internal appeal rights with CVS Caremark. If the internal appeal is denied, external review may be available depending on plan type and denial reason.
Does Aetna cover Foundayo?
Aetna uses CVS Caremark as its pharmacy benefit manager (both are part of CVS Health). The public Aetna/CVS Standard Control Plan PDF we checked did not list Foundayo or orforglipron. Aetna coverage remains plan-specific — verify your plan directly.
Why does CVS Caremark prefer Wegovy over Foundayo?
In May 2025, CVS Caremark announced a preferred partnership with Novo Nordisk placing Wegovy on its largest commercial template formularies as the preferred GLP-1 for weight loss. CVS stated it continues to prefer similar medications including Wegovy and that Zepbound is no longer included in its Standard Control, Advanced Control, and Value formularies. Foundayo is from Eli Lilly — the same manufacturer as the excluded Zepbound.
Can I use the Foundayo Savings Card with CVS Caremark?
Yes, if your CVS Caremark plan covers Foundayo AND you have commercial (non-government) insurance. The card drops eligible patients' cost to as little as $25/month with a $1,000 annual savings cap. Medicare, Medicare Part D, Medicare Advantage, Medicaid, TRICARE, VA, and DoD beneficiaries are not eligible.
What does 'drug not found' mean on Caremark.com for Foundayo?
It usually means one of three things: (1) Foundayo hasn't been loaded into your plan's formulary database yet — common for drugs less than 90 days old, (2) the search tool didn't recognize the brand name — try 'orforglipron,' or (3) your plan excludes the drug entirely. Call CVS Caremark to clarify which one applies.
Does CVS Caremark cover Foundayo for type 2 diabetes?
Foundayo is currently FDA-approved only for chronic weight management. Eli Lilly says orforglipron is being studied as a potential treatment for type 2 diabetes and has been submitted for weight management and/or type 2 diabetes in more than 40 countries. A separate CVS Caremark coverage review would apply if a diabetes indication is approved.
How much does Foundayo cost with CVS Caremark if covered?
If your plan covers Foundayo and you qualify for the Foundayo Savings Card, as little as $25/month for up to 10 fills per year (with a $1,000 annual savings cap). Your actual cost depends on your plan's copay tier, deductible status, and coinsurance structure.
How do I request a formulary exception for Foundayo on CVS Caremark?
Your prescriber submits a formulary exception request, typically electronically through their EHR via Surescripts or CoverMyMeds, or by fax. The request needs to document medical necessity for Foundayo specifically over the preferred alternative. Strong cases include documented prior trial of preferred alternatives with inadequate response or intolerable side effects.
Can Ro handle CVS Caremark prior authorization for Foundayo?
Ro says its insurance concierge submits prior authorization paperwork as part of its weight-loss program. If your CVS Caremark plan covers Foundayo with PA required, Ro's team handles the ePA and follows up with the insurer. Ro cannot override a plan exclusion — that's a benefit design decision your employer made.
Is CVS Caremark the same as CVS Pharmacy?
No. CVS Caremark manages your prescription drug benefit (the PBM); CVS Pharmacy is the retail pharmacy where you might fill prescriptions. A CVS Pharmacy can dispense Foundayo whether or not your CVS Caremark plan covers it — the question is just whether you pay the insurance rate or the self-pay rate.
Is Foundayo compounded?
No. Foundayo is an FDA-approved brand-name oral GLP-1 medication manufactured by Eli Lilly. It is not a compounded product. Compounded GLP-1 products are a separate category with different regulatory, clinical, and insurance considerations.
The bottom line: your next 24 hours
You don't need to solve everything today. You need to do one thing: find out what your specific CVS Caremark plan actually says about Foundayo. Everything else flows from that single data point.
If you have 5 minutes right now:
Log into Caremark.com, search Foundayo and orforglipron, screenshot the result. Use the script above when you call.
If you'd rather have someone else do the insurance work:
Start Ro's free GLP-1 Insurance Coverage Checker →Ro contacts your insurance company, verifies Foundayo coverage, identifies PA requirements, and sends you a personalized report. If PA is required, Ro's insurance concierge handles the paperwork.
If your result is "not covered" and you want to start treatment anyway:
Self-pay starts at $149/month for the 0.8mg starter dose through LillyDirect, Ro, or Sesame Care. Ro and Sesame both carry Foundayo at Lilly's published self-pay prices.
If you're not even sure which GLP-1 is right for you:
Take our free 60-second GLP-1 matching quiz →Related coverage guides
Last verified: April 24, 2026 by The RX Index Editorial Team. Verified monthly on the 1st of each month or within 48 hours of any material change. Next scheduled review: May 1, 2026.
Disclosure: The RX Index earns referral fees from Ro and Sesame Care through the links on this page. We do not earn fees from CVS Caremark, Eli Lilly, Novo Nordisk, or LillyDirect. Provider recommendations reflect our editorial judgment on fit, not commission rates. This page is educational and not a coverage determination — your specific CVS Caremark plan is the source of truth for your actual benefits.